Literature DB >> 20571933

Tarenflurbil in patients with mild Alzheimer's disease.

Karen Marder1.   

Abstract

Entities:  

Year:  2010        PMID： 20571933     DOI： 10.1007/s11910-010-0130-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  2 in total

Review 1.  An update on treatment and prevention strategies for Alzheimer's disease.

Authors:  Judith Neugroschl; Mary Sano
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Authors:  Gordon K Wilcock; Sandra E Black; Suzanne B Hendrix; Kenton H Zavitz; Edward A Swabb; Mark A Laughlin
Journal:  Lancet Neurol       Date:  2008-04-29       Impact factor: 44.182
  2 in total
  1 in total

1.  Inhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitrates.

Authors:  Isaac T Schiefer; Samer Abdul-Hay; Huali Wang; Michael Vanni; Zhihui Qin; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2011-03-15       Impact factor: 7.446
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.